Literature DB >> 2991964

Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat.

C T Dourish, S J Cooper, S R Philips.   

Abstract

The behavioural effects of systemic and intrastriatal injections of the dopamine agonists piribedil and apomorphine in male rats were examined. Bilateral application of piribedil (50 and 100 micrograms) or apomorphine (5, 10 and 20 micrograms) to the striatum produced yawning and chewing mouth movements accompanied by intermittent stretching and sexual arousal. Low doses of piribedil (1.25 and 2.5 mg/kg) and apomorphine (0.1 and 0.2 mg/kg) injected SC produced an identical yawning syndrome. Previous work has suggested that yawning elicited by systemic dopamine agonist treatment is a consequence of dopamine autoreceptor stimulation. Similarly, the most likely explanation of the present data is that yawning elicited by systemic and central dopamine agonist treatment was due to activation of dopamine autoreceptors. Systemic injection of haloperidol and scopolamine abolished yawning induced by intrastriatal piribedil and these data provide tentative support for the proposal that a dopamine-acetylcholine link may be involved in the expression of yawning.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991964     DOI: 10.1007/bf00431705

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  Behavioural changes in animals after intracisternal injection with adrenocorticotrophic hormone and melanocyte-stimulating hormone.

Authors:  W FERRARI
Journal:  Nature       Date:  1958-03-29       Impact factor: 49.962

2.  Drugs affecting dopamine neurons and yawning behavior.

Authors:  E Mogilnicka; V Klimek
Journal:  Pharmacol Biochem Behav       Date:  1977-10       Impact factor: 3.533

3.  Hypophysectomy prevents yawning and penile erection but not hypomotility induced by apomorphine.

Authors:  G Serra; M Collu; S Loddo; G Celasco; G L Gessa
Journal:  Pharmacol Biochem Behav       Date:  1983-12       Impact factor: 3.533

4.  Piribedil: behavioural, neurochemical and clinical profile of a dopamine agonist.

Authors:  C T Dourish
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1983       Impact factor: 5.067

5.  The Yawning elicited by alpha-melanocyte-stimulating hormone involves serotonergic-dopaminergic-cholinergic neuron link in rats.

Authors:  K Yamada; T Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-04       Impact factor: 3.000

6.  Neurochemical and behavioral evidence for a selective presynaptic dopamine receptor agonist.

Authors:  D P Goodale; D B Rusterholz; J P Long; J R Flynn; B Walsh; J G Cannon; T Lee
Journal:  Science       Date:  1980-12-05       Impact factor: 47.728

7.  Effects of apomorphine, TL-99 and 3-PPP on yawning in rats.

Authors:  E Mogilnicka; C G Boissard; A Delini-Stula
Journal:  Neuropharmacology       Date:  1984-01       Impact factor: 5.250

8.  Potentiation of the behavioural effects of the antidepressant phenelzine by deuterium substitution.

Authors:  C T Dourish; K M Dewar; L E Dyck; A A Boulton
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.

Authors:  K Yamada; T Furukawa
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530

10.  Cycloheximide prevents apomorphine-induced yawning, penile erection and genital grooming in rats.

Authors:  G Serra; W Fratta; M Collu; L Napoli-Farris; G L Gessa
Journal:  Eur J Pharmacol       Date:  1982-12-24       Impact factor: 4.432

View more
  13 in total

Review 1.  Do autoreceptors mediate dopamine agonist--induced yawning and suppression of exploration? A critical review.

Authors:  L Ståhle
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.

Authors:  A J Stoessl; C T Dourish; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Effects of adenosine agents on apomorphine-induced yawning in rats.

Authors:  M R Zarrindast; F Fatehi; M Mohagheghi-Badi
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

Review 4.  Comparative tolerability and efficacy of treatments for impotence.

Authors:  W Meinhardt; R F Kropman; P Vermeij
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

5.  Conditioning of pre- and post-synaptic behavioural responses to the dopamine receptor agonist apomorphine in rats.

Authors:  H G Möller; K Nowak; K Kuschinsky
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  An observational analysis of the effect of the selective kappa opioid agonist, U-50,488H, on feeding and related behaviours in the rat.

Authors:  A Jackson; S J Cooper
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  Studies on interactions between conditioned and unconditioned behavioural responses to apomorphine in rats.

Authors:  H G Möller; K Nowak; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

8.  Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.

Authors:  M R Zarrindast; M Poursoltan
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

9.  Conditioning of behavioural effects produced by an intermediate dose of apomorphine: hypokinesia, ptosis and stereotypies.

Authors:  K Nowak; K Kuschinsky
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

10.  Effects of dorsal striatal infusions of R(-)-propylnorapomorphine on kappa-opioid-mediated locomotor activity in the young rat: possible role of the indirect pathway.

Authors:  S Charntikov; L R Halladay; M S Herbert; E M Marquez; S A McDougall
Journal:  Neuroscience       Date:  2008-06-14       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.